4-122893745-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001361665.2(FGF2):​c.*1349G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.413 in 152,096 control chromosomes in the GnomAD database, including 15,851 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 15846 hom., cov: 33)
Exomes 𝑓: 0.44 ( 5 hom. )

Consequence

FGF2
NM_001361665.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.190

Publications

19 publications found
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
NUDT6 (HGNC:8053): (nudix hydrolase 6) This gene overlaps and lies on the opposite strand from FGF2 gene, and is thought to be the FGF2 antisense gene. The two genes are independently transcribed, and their expression shows an inverse relationship, suggesting that this antisense transcript may regulate FGF2 expression. This gene has also been shown to have hormone-regulatory and antiproliferative actions in the pituitary that are independent of FGF2 expression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.552 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF2NM_001361665.2 linkc.*1349G>A 3_prime_UTR_variant Exon 3 of 3 ENST00000644866.2 NP_001348594.1
NUDT6NM_007083.5 linkc.554-520C>T intron_variant Intron 4 of 4 ENST00000304430.10 NP_009014.2 P53370-1
FGF2NM_002006.6 linkc.*1349G>A 3_prime_UTR_variant Exon 3 of 3 NP_001997.5 P09038-4
NUDT6NM_198041.3 linkc.47-520C>T intron_variant Intron 4 of 4 NP_932158.1 P53370-2B4DG76

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF2ENST00000644866.2 linkc.*1349G>A 3_prime_UTR_variant Exon 3 of 3 NM_001361665.2 ENSP00000494222.1 P09038-2
NUDT6ENST00000304430.10 linkc.554-520C>T intron_variant Intron 4 of 4 1 NM_007083.5 ENSP00000306070.5 P53370-1

Frequencies

GnomAD3 genomes
AF:
0.413
AC:
62737
AN:
151942
Hom.:
15840
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.480
Gnomad ASJ
AF:
0.456
Gnomad EAS
AF:
0.452
Gnomad SAS
AF:
0.251
Gnomad FIN
AF:
0.595
Gnomad MID
AF:
0.299
Gnomad NFE
AF:
0.557
Gnomad OTH
AF:
0.439
GnomAD4 exome
AF:
0.444
AC:
16
AN:
36
Hom.:
5
Cov.:
0
AF XY:
0.563
AC XY:
9
AN XY:
16
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AF:
0.500
AC:
1
AN:
2
European-Finnish (FIN)
AF:
0.750
AC:
3
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.423
AC:
11
AN:
26
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.413
AC:
62747
AN:
152060
Hom.:
15846
Cov.:
33
AF XY:
0.410
AC XY:
30484
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.111
AC:
4612
AN:
41508
American (AMR)
AF:
0.480
AC:
7335
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
1583
AN:
3468
East Asian (EAS)
AF:
0.452
AC:
2337
AN:
5174
South Asian (SAS)
AF:
0.251
AC:
1211
AN:
4822
European-Finnish (FIN)
AF:
0.595
AC:
6275
AN:
10538
Middle Eastern (MID)
AF:
0.295
AC:
86
AN:
292
European-Non Finnish (NFE)
AF:
0.557
AC:
37822
AN:
67960
Other (OTH)
AF:
0.441
AC:
931
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4869
6492
8115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
556
1112
1668
2224
2780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.508
Hom.:
34331
Bravo
AF:
0.397
Asia WGS
AF:
0.358
AC:
1246
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.0
DANN
Benign
0.34
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3804158; hg19: chr4-123814900; API